Category Archives: U.S. Policy and Funding

Birx, Farmer: Global AIDS lessons can inform, equip hepatitis response

By on .

WASHINGTON, DC — Health leaders who gathered Wednesday at the White House to commemorate World Hepatitis Day agreed that recognition of the needless toll and continuing threat of that global, infectious and often deadly disease has been a long time coming. They also cited practical promise in the recent World Health Assembly Hepatitis Resolution that […]

Gilead hepatitis C drug price deal leaves global treatment access advocates underwhelmed

By on .

When the U.S. Food and Drug Administration approved sofosbuvir for the treatment of chronic hepatitis C in early December, it was a step that was “expected to dramatically improve outcomes for many patients,” as one report put it. But how many was a big question, as we noted here. While the drug shortens treatment for […]